Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants is a research paper published in Clinical Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 7.3. It has been cited 419 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.906
From this paper's citation signal
Citation Network Contribution
6.4
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
National Institutes of Health
Grant: UL1TR001425
National Institutes of Health
Grant: U24HG010135
National Institutes of Health
Grant: R24GM115264
National Institute of Child Health and Human Development
Grant: R01HD098757
National Institute of Child Health and Human Development
Grant: R01HD099775
NHGRI NIH HHS
Grant: U24 HG013077
NHGRI NIH HHS
Grant: U24 HG010615
NIGMS NIH HHS
Grant: R24 GM123930
Patient-Centered Outcomes Research Institute
FWCI
85.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals